Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist-Reference-Cited by-同舟云学术

Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist

Published:2024-04 Issue: Volume:173 Page:116331
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Moon An-Na^ORCID,Briand François^ORCID,Breyner Natalia,Song Dong-Keun^ORCID,Madsen Martin Rønn,Kim Hongbin,Choi Keonwoo^ORCID,Lee Yoonsuk,Namkung Wan^ORCID

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Reference51 articles.

1. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States;Younossi;Clin. Gastroenterol. Hepatol.,2021

2. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes;Younossi;JHEP Rep.,2022

3. Global burden of NAFLD and chronic liver disease among adolescents and young adults;Paik;Hepatology,2022

4. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus;Ferguson;Nat. Rev. Endocrinol.,2021

5. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR;Wang;Mol. Cell,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Five‐Membered Aromatic Rings Containing N and O in Modulating Bile Acid Receptors: An Overview;ChemMedChem;2025-07-11

2. The potential of 4-Methylumbelliferone to be repurposed for treating liver fibrosis;2025-05-23

3. SINTESIS SENYAWA METABOLIT OLEH MIKROBIOTA SALURAN CERNA DAN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): TINJAUAN PADA SCFA DAN BCAA;Journal of Nutrition College;2025-01-02

4. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease;Antioxidants;2024-11-14

5. Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR;Phytomedicine;2024-07